Analyst Sachin Mittal keeps his “buy” call, arguing AvePoint is largely immune to AI disruption despite broader SaaS multiple resets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results